Literature DB >> 29761559

Conditional depletion of GSK3b protects oligodendrocytes from apoptosis and lessens demyelination in the acute cuprizone model.

Bin Xing1, Lauren E Brink1, Kelly Maers1, Mara L Sullivan2, Richard J Bodnar1, Donna B Stolz2, Franca Cambi1,3,4.   

Abstract

Apoptosis is recognized as the main mechanism of oligodendrocyte loss in Multiple Sclerosis caused either by immune mediated injury (Barnett & Prineas, ) or a direct degenerative process (oligodendrogliapathy; Lucchinetti et al., ). Cuprizone induced demyelination is the result of non-immune mediated apoptosis of oligodendrocytes (OL) and represents a model of oligodendrogliapathy (Simmons, Pierson, Lee, & Goverman, ). Glycogen Synthase Kinase (GSK) 3b has been shown to be pro-apoptotic for cells other than OL. Here, we sought to investigate whether GSK3b plays a role in cuprizone-induced apoptosis of OL by using a novel inducible conditional knockout (cKO) of GSK3b in mature OL. While depletion of GSK3b has no effect on survival of uninjured OL, it increases survival of mature OL exposed to cuprizone. We show that GSK3b-deficient OLs are protected against caspase-dependent, but not against caspase-independent apoptosis. Active GSK3b is present in the nuclei of OL at peak of caspase-dependent apoptosis. Significant preservation of myelinated axons is associated with GSK3b depletion and glial cell activation is markedly reduced. Collectively, the data show that GSK3b is pro-apoptotic for caspase-dependent cell death, likely through activation of nuclear GSK3b and its depletion promotes survival of oligodendrocytes and attenuates myelin loss.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  GSK3b; cell death; glia; multiple sclerosis

Mesh:

Substances:

Year:  2018        PMID: 29761559     DOI: 10.1002/glia.23453

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  7 in total

1.  Effects of HIV-1 Tat on oligodendrocyte viability are mediated by CaMKIIβ-GSK3β interactions.

Authors:  Shiping Zou; Joyce M Balinang; Jason J Paris; Kurt F Hauser; Babette Fuss; Pamela E Knapp
Journal:  J Neurochem       Date:  2019-03-15       Impact factor: 5.372

Review 2.  The role of oligodendrocytes and their progenitors on neural interface technology: A novel perspective on tissue regeneration and repair.

Authors:  Steven M Wellman; Franca Cambi; Takashi Dy Kozai
Journal:  Biomaterials       Date:  2018-08-22       Impact factor: 12.479

3.  Cuprizone-induced oligodendrocyte loss and demyelination impairs recording performance of chronically implanted neural interfaces.

Authors:  Steven M Wellman; Kelly Guzman; Kevin C Stieger; Lauren E Brink; Sadhana Sridhar; Mitchell T Dubaniewicz; Lehong Li; Franca Cambi; Takashi D Y Kozai
Journal:  Biomaterials       Date:  2020-02-06       Impact factor: 12.479

4.  Conditional depletion of Fus in oligodendrocytes leads to motor hyperactivity and increased myelin deposition associated with Akt and cholesterol activation.

Authors:  Kelly M Guzman; Lauren E Brink; Guillermo Rodriguez-Bey; Richard J Bodnar; Lisha Kuang; Bin Xing; Mara Sullivan; Hyun J Park; Erik Koppes; Haining Zhu; Quasar Padiath; Franca Cambi
Journal:  Glia       Date:  2020-03-18       Impact factor: 7.452

Review 5.  GSK3: A Kinase Balancing Promotion and Resolution of Inflammation.

Authors:  Leonie Hoffmeister; Mareike Diekmann; Korbinian Brand; René Huber
Journal:  Cells       Date:  2020-03-28       Impact factor: 6.600

Review 6.  Glycogen Synthase Kinase-3 Inhibitors: Preclinical and Clinical Focus on CNS-A Decade Onward.

Authors:  Sara Melisa Arciniegas Ruiz; Hagit Eldar-Finkelman
Journal:  Front Mol Neurosci       Date:  2022-01-21       Impact factor: 5.639

7.  Short-Chain Fatty Acids Reduce Oligodendrocyte Precursor Cells Loss by Inhibiting the Activation of Astrocytes via the SGK1/IL-6 Signalling Pathway.

Authors:  Yanmin Gao; Di Xie; Yang Wang; Lei Niu; Hua Jiang
Journal:  Neurochem Res       Date:  2022-09-13       Impact factor: 4.414

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.